Cáncer de mama: valor pronóstico del estado «TN» versus perfil de expresión génica tumoral Juan Antonio Mieza Arana; Zabalza Estevez; Lopez Ruiz; María del Mar Vivanco Ruiz; Lopez Maseda;

Prognostic value of tumor-infiltrating lymphocytes (TILS) and their association with clinicopathological features in breast cancer: A retrospective study involving 53 cases Oussama Belkacem; Dhouha Bacha; Nabil Rahoui; Mohamed Dhia Zran; Ahlem Lahmar; Sana Ben Slama;

Therapeutic implications of antiangiogenic agents and poly-adenosine diphosphate ribose polymerase (PARP) inhibitors in breast cancer: Current status and future perspectives Muhammad Adil; Ghazanfar Abbas; Mavara Iqbal; Sarmad Rasheed; Shamsa Kanwal;